Swedbank
ONC

Swedbank’s BeOne Medicines Ltd ONC Stock Holding History

Swedbank’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,599
Closed -$2.37M – 708
2024
Q2 		$2.37M Hold
16,599
– – ﹤0.01% 601
2024
Q1 		$2.6M Sell
16,599
-3,665
-18% -$590K ﹤0.01% 585
2023
Q4 		$3.65M Hold
20,264
– – 0.01% 549
2023
Q3 		$3.64M Hold
20,264
– – 0.01% 546
2023
Q2 		$3.61M Hold
20,264
– – 0.01% 553
2023
Q1 		$4.37M Hold
20,264
– – 0.01% 527
2022
Q4 		$4.46M Buy
20,264
+3,845
+23% +$705K 0.01% 515
2022
Q3 		$2.21M Hold
16,419
– – 0.01% 580
2022
Q2 		$2.66M Hold
16,419
– – 0.01% 577
2022
Q1 		$3.1M Hold
16,419
– – 0.01% 585
2021
Q4 		$4.49M Buy
16,419
+11,021
+204% +$3.72M 0.01% 573
2021
Q3 		$1.96M Hold
5,398
– – ﹤0.01% 648
2021
Q2 		$1.85M Buy
+5,398
New +$1.79M ﹤0.01% 658

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Swedbank's ONC Position: Q3 2024 in Review

Swedbank sold out of BeOne Medicines Ltd (ONC) in Q3 2024, closing a stake of 16,599 shares — an estimated $2.37M sold.

Swedbank first reported a position in ONC in Q2 2021 and held it in 13 quarters. The position peaked at $4.49M in Q4 2021. 228 funds tracked by Wall St. Rank hold ONC as of Q3 2024.

  • Swedbank reported no remaining BeOne Medicines Ltd position as of Q3 2024 after selling out during the quarter.
  • Swedbank sold 16,599 BeOne Medicines Ltd shares in Q3 2024, an estimated $2.37M.
  • Swedbank first reported a position in BeOne Medicines Ltd in Q2 2021 and held it in 13 quarters.
  • Swedbank's BeOne Medicines Ltd position peaked at $4.49M in Q4 2021.
  • 228 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2024.

Based on Swedbank's 13F filing for Q3 2024, filed 11 Oct 2024.